tiprankstipranks
Trending News
More News >
Genedx Holdings Corp. (WGS)
NASDAQ:WGS
US Market

GeneDx Holdings (WGS) Financial Statements

Compare
894 Followers

GeneDx Holdings Financial Overview

GeneDx Holdings's market cap is currently $2.25B. The company's EPS TTM is $0.14; its P/E ratio is -166.38; GeneDx Holdings is scheduled to report earnings on February 23, 2026, and the estimated EPS forecast is $-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 427.54M$ 305.45M$ 202.57M$ 234.69M$ 212.19M
Gross Profit$ 298.17M$ 194.40M$ 90.01M$ -26.75M$ -16.60M
Operating Income$ -11.80M$ -23.21M$ -180.60M$ -667.65M$ -446.15M
EBITDA$ 6.63M$ -1.26M$ -136.46M$ -398.20M$ -220.75M
Net Income$ -21.02M$ -52.29M$ -175.77M$ -548.98M$ -245.39M
Balance Sheet
Cash & Short-Term Investments$ 171.28M$ 141.19M$ 130.15M$ 137.40M$ 400.57M
Total Assets$ 570.19M$ 419.38M$ 418.76M$ 545.26M$ 554.09M
Total Debt$ 151.95M$ 116.17M$ 119.77M$ 77.13M$ 32.85M
Net Debt$ 46.95M$ 30.96M$ 20.09M$ -60.27M$ -367.72M
Total Liabilities$ 262.01M$ 174.13M$ 190.74M$ 291.56M$ 165.99M
Stockholders' Equity$ 308.18M$ 245.25M$ 228.02M$ 253.71M$ 388.10M
Cash Flow
Free Cash Flow$ 14.26M$ -33.99M$ -185.86M$ -333.48M$ -211.22M
Operating Cash Flow$ 33.28M$ -28.50M$ -180.15M$ -319.15M$ -190.43M
Investing Cash Flow$ -61.52M$ -30.13M$ -43.73M$ -141.33M$ -20.79M
Financing Cash Flow$ 48.02M$ 44.16M$ 186.24M$ 197.31M$ 493.73M
Currency in USD

GeneDx Holdings Earnings and Revenue History

GeneDx Holdings Debt to Assets

GeneDx Holdings Cash Flow

GeneDx Holdings Forecast EPS vs Actual EPS